Back to Treatments

Treatment

Anti-fibrotic agents (e.g., Pirfenidone, Nintedanib)

1
Conditions
4
Trials
80
Participants
35%
Average Safety

Condition Evidence

Silicosis

4 trials · 80 participants

25% effectiveness · 35% safety
Anti-fibrotic agents (e.g., Pirfenidone, Nintedanib) | DFDA